Search Results

Displaying Results 1526-1550 of 2598 "'DNA'"

Nov 06, 2025, 10:18 ET Wolverine Puts Boots on the Ground in "Landman" for a New Partnership with Paramount+'s Blockbuster Hit

the work, sacrifice, and legacy of the oil patch, we knew this was an opportunity for us to amplify stories that reflect our consumer and Wolverine's DNA. Both "Landman" and Wolverine celebrate the resilience, complexity, and humanity of modern tradespeople, as well as their families and communities."

More news about: Wolverine


Nov 06, 2025, 10:00 ET CODiE Awards Honor Nearpod + Freckle as Best Mathematics Instructional Solution

DnA for Best Content Authoring Development or Curation Solution,

More news about: Renaissance


Nov 06, 2025, 08:30 ET BJ's RESTAURANT REMIXES ITS ICONIC DEEP DISH PIZZA, TAKING THE BELOVED CLASSIC TO ALL NEW HEIGHTS

going back to the heart of its story, where it all began: pizza. Since 1978, BJ's signature take on Chicago-style deep dish has been at the heart of its DNA, often serving as a catalyst for bringing friends, family and communities together to share a good time over a great slice. Now, for the first time in

More news about: BJ’s Restaurants, Inc.


Nov 06, 2025, 08:00 ET Cure by Deerfield Middle East Health Accelerator Selects 15 Startups for Inaugural Cohort

bionic prosthetics for limb differences.  DoriNano (USA): Programmable nanoparticle delivery (DNA-origami) powering oncology and partnered pipelines. EndoMD Health (USA): Digital-first endocrinology

More news about: Cure


Nov 06, 2025, 04:46 ET WuXi XDC Named the Winner of "Best CDMO" and "Best CRO" at 2025 World ADC Awards

efficiency to facilitate the smooth and rapid progression of projects. WuXi XDC has successfully supported global customers in advancing ADCs/XDCs from the DNA stage to IND applications within 15 months, and assisted customers in efficiently completing the transition from late-stage development to BLA within

More news about: WuXi XDC


Nov 06, 2025, 04:00 ET Nucleome Therapeutics founder Professor James Davies and Oxford University publish paper in prestigious journal Cell

changes in the intricate structure of DNA leads to conditions like heart disease, autoimmune disorders and cancer.' For more than two decades, scientists have known the full sequence of the human genome — the three billion "letters" of DNA that make up our genetic code. But exactly

More news about: Nucleome Therapeutics


Nov 06, 2025, 02:19 ET Millennium Technology Prize opens its nomination period for innovations for a better life

future. The Prize has been awarded for world-changing innovations such as ethical stem cell research, an open-source operating system, and next-generation DNA sequencing. The latest Millennium Technology Prize in 2024 was awarded to Professor Bantval Jayant Baliga of North Carolina

More news about: Millenium Technology Prize


Nov 06, 2025, 02:16 ET Millennium Technology Prize opens its nomination period for innovations for a better life

future. The Prize has been awarded for world-changing innovations such as ethical stem cell research, an open-source operating system, and next-generation DNA sequencing. The latest Millennium Technology Prize in 2024 was awarded to Professor Bantval Jayant Baliga of North Carolina

More news about: Millenium Technology Prize


Nov 06, 2025, 02:11 ET Kanazawa University research: Protein droplets in the nucleus guard against cancer

atomic force microscopy (HS-AFM): captured how CHD1 proteins interact with DNA and assemble into condensates at the nanoscale. Droplet assays: tested how CHD1 forms condensates in the presence of DNA, RNA, and nucleosomes. Confocal microscopy: visualized

More news about: Kanazawa University


Nov 06, 2025, 02:09 ET RSPO, 소규모 농가 포용 확대와 기술 도입 확대 촉구

말레이시아 과학원(Academy of Sciences Malaysia) 생물•농업•환경과학 분야 의장인 라비가데비 삼반타무르티(Ravigadevi Sambanthamurthi) 박사는 기조연설에서 "과학은 이미 종자 품질 개선을 위한 DNA 검사부터 순환 경제에서의 바이오매스 활용에 이르기까지 지속가능한 생산을 촉진하기 위한 획기적인 해법을 제시해왔다"면서 "오늘날 우리의 가장 큰 도전은 더 이상 혁신이 아니라 실행"이라며 지속가능한 팜유 산업 발전을 위한 과학적 해결책의 중요성을 강조했다. 영국 왕립학회 회원(Fellow

More news about: Roundtable On Sustainable Palm Oil


Nov 06, 2025, 02:06 ET RSPO drängt auf eine breitere Einbeziehung der Kleinbauern und eine verstärkte Einführung von Technologien

Rolle wissenschaftlicher Lösungen bei der Förderung des nachhaltigen Palmölsektors hervor. „Die Wissenschaft hat bereits bahnbrechende Lösungen - von DNA-Tests für die Saatgutqualität bis hin zur Nutzung von Biomasse in einer Kreislaufwirtschaft - entwickelt, um die nachhaltige Produktion voranzutreiben.

More news about: Roundtable On Sustainable Palm Oil


Nov 06, 2025, 01:50 ET RSPO pede maior inclusão de pequenos agricultores e maior adoção de tecnologia

destacou o papel das soluções científicas no avanço do setor de óleo de palma sustentável. "A ciência já forneceu soluções inovadoras - desde testes de DNA para a qualidade das sementes até a utilização da biomassa em uma economia circular - para promover a produção sustentável. Nosso maior desafio hoje

More news about: Roundtable On Sustainable Palm Oil


Nov 05, 2025, 19:42 ET The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia

precise single-base correction without DNA double-strand breaks, offering superior safety over the gene-editing therapies based on CRISPR. tBE avoids potential safety risks such as p53 activation, chromosomal damage, off-target effects, and liver toxicity caused by DNA double-strand breaks. Preclinical animal

More news about: CorrectSequence Therapeutics


Nov 05, 2025, 19:00 ET The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia

precise single-base correction without DNA double-strand breaks, offering superior safety over the gene-editing therapies based on CRISPR. tBE avoids potential safety risks such as p53 activation, chromosomal damage, off-target effects, and liver toxicity caused by DNA double-strand breaks. Preclinical animal

More news about: CorrectSequence Therapeutics


Nov 05, 2025, 17:16 ET Illumina Responds to Positive Updates from Chinese Ministry of Commerce

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in

More news about: Illumina, Inc.


Nov 05, 2025, 13:34 ET Carbliss Leads High Performance Wisconsin Partnership with La Macchia Group, Forty48 Competition, and James French Racing

new audiences together by using each brand's platform to spotlight the others. "Each of these Wisconsin brands shares the same DNA: innovation, drive, and a refusal to settle," said Adam Kroener, CEO and Co-Founder of Carbliss. "This partnership is more than a race program; it's

More news about: Carbliss Premium Hand Crafted Cocktails


Nov 05, 2025, 12:03 ET New environmental DNA test could help rare hammerhead sharks fight extinction

struggled to study them. With their lives and habitats largely unknown, conservation efforts have fallen behind — until now. Cardeñosa's new environmental DNA (eDNA) test could change the fate of these critically endangered sharks. "Just by screening different locations along their distribution

More news about: Florida International University


Nov 05, 2025, 11:04 ET Product DNA Brings Real-Time Climate Accountability to First Commercial Deployment of ATS Energy's Solid-State Generator

in practice—measurable, auditable, and integrated from day one." About Product DNA  Product DNA (PDNA) is a global traceability and sustainability intelligence innovator transforming how organizations prove and communicate their

More news about: Product DNA


Nov 05, 2025, 11:00 ET ATS Energy Announces World's First Commercial Agreement for Deployment of a Megawatt-Scale Solid-State Generator at The Earthshot Prize Summit in Rio de Janeiro, Brazil

strengthen the environmental impact of the project, the agreement will incorporate a blockchain-secured emissions traceability system provided by Product DNA, a leading sustainability intelligence company based in Lausanne, Switzerland. This platform will deliver real-time, audit-ready reporting across Scope

More news about: Advanced Thermovoltaic Systems


Nov 05, 2025, 10:30 ET Children's Brain Tumor Network Names Dr. John Prensner as New Scientific Co-Chair

we're building the foundation for tomorrow's breakthroughs in care." The Prensner Lab studies the non-coding genome—the 98% of DNA outside known genes—and how RNA translation and the dark proteome drive childhood brain tumors such as medulloblastoma, ATRT, and DIPG/DMG. His research

More news about: Children’s Brain Tumor Network


Nov 05, 2025, 09:00 ET Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to

More news about: Co-Diagnostics


Nov 05, 2025, 09:00 ET MarginEdge Named an Inc. 2025 Power Partner for Helping Restaurants Run Smarter

data-driven decisions. What sets MarginEdge apart in the restaurant technology industry is that hospitality is baked into its DNA. More than 70% of its U.S.-based team has worked in restaurants. From GMs to chefs to operators, this shared experience drives the company's mission

More news about: MarginEdge


Nov 05, 2025, 08:53 ET Meet the "Strava for Good": LiveImpact.io Soft Launches with Free Lifetime Access

features, causes, and functionality over the coming months based on early user input. "This first group of members will shape the DNA of LiveImpact.io," said Zwetsch. "We're starting small, but with a clear purpose, to prove that when you make everyday action visible, people will take

More news about: Live Impact, LLC


Nov 05, 2025, 08:30 ET Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting

has been critical to the development of groundbreaking cancer therapies, including Tecentriq® (atezolizumab), patient-specific neo-antigen mRNA and DNA vaccines, T cell-engaging bispecific antibodies and novel immunotherapies such as tiragolumab (anti-TIGIT). Dr. Mellman will receive the award and present,

More news about: Parker Institute for Cancer Immunotherapy


Nov 05, 2025, 08:00 ET IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025

operations. Furthermore, the company shared how IDT developed a tailored in-house assay for high-sensitivity quantification and reliable sizing of host cell DNA. Aligning with this year's congress theme, "Connecting Innovation from Research to Commercial Manufacture," the company emphasized

More news about: SK bioscience


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.